Item 1.01 Entry into a Material Definitive Agreement
On June 15, 2023 (the "Closing Date"), ATI Physical Therapy, Inc. (the
"Company") completed a transaction (the "Transaction") to enhance the Company's
liquidity, as previously described in the Current Report on Form 8-K filed by
the Company with the U.S. Securities and Exchange Commission on April 21, 2023
(the "Signing Date 8-K"), and as approved by the Company's stockholders at the
Company's annual meeting of stockholders held on June 13, 2023.
Signing Date Definitive Documents
On the Closing Date, certain previously executed agreements became effective,
including (i) Amendment No. 2 to Credit Agreement (the "Credit Agreement
Amendment"), by, among others, ATI Holdings Acquisition, Inc., as borrower
("Opco"), Wilco Intermediate Holdings, Inc. ("Holdings"), Barclays Bank PLC, as
administrative agent and issuing bank (the "Administrative Agent"), and the
lenders party thereto, which amends that certain Credit Agreement, dated as of
February 24, 2022 (the "2022 Credit Agreement" and together with the Credit
Agreement Amendment, the "Credit Agreement"), by, among others, Opco, Holdings,
the Administrative Agent and the lenders party thereto, (ii) a Second Lien Note
Purchase Agreement (the "Original Note Purchase Agreement"), by, among others,
the Company, Wilco Holdco, Inc. ("Wilco"), Holdings, Opco, the purchasers from
time to time party thereto (the "Purchasers") and Wilmington Savings Fund
Society, FSB, as purchaser representative (the "Purchaser Representative") and
(iii) certain other definitive agreements relating to the Transaction (such
documents referred to collectively as the "Signing Date Definitive Documents").
Closing Date Definitive Documents
In addition, on the Closing Date, the Company entered into or filed with the
Secretary of State of the State of Delaware, as applicable, certain other
agreements (collectively, the "Closing Date Definitive Documents") to implement
certain terms of the previously described Amended and Restated Transaction
Support Agreement (the "A&R TSA"), dated as of April 17, 2023, by and among the
Company and certain of the Company's affiliates, certain of its first lien
lenders under the 2022 Credit Agreement, the Administrative Agent, holders of
its Series A Senior Preferred Stock (the "Preferred Equityholders") and holders
of the majority of its Class A common stock, par value $0.0001 per share (the
"Common Stock"). The Closing Date Definitive Documents include (i) the First
Amendment to Note Purchase Agreement (together with the Original Note Purchase
Agreement, the "Note Purchase Agreement"), dated as of the Closing Date, by and
among the Company, Wilco, Holdings, Opco, the Purchasers party thereto (in such
capacity, the "First Amendment Purchasers") and the Purchaser Representative,
pursuant to which the First Amendment Purchasers agreed to purchase, and the
Company agreed to issue, an additional $3,243,302.02 aggregate principal amount
of Notes, (ii) the Consent to Amendment No. 2 to Credit Agreement, dated as of
the Closing Date, by, among others, Opco, Holdings, the lenders party thereto
and the Administrative Agent, which amends the Credit Agreement Amendment, (iii)
the First Amended and Restated Certificate of Designation of Series A Senior
Preferred Stock of the Company, dated as of June 15, 2023 (the "A&R Series A
COD"), which, as agreed under the A&R TSA, (A) revised the Preferred
Equityholders' preexisting rights to designate and elect one director to the
Company's board of directors (the "Board") to provide that the Preferred
Equityholders have the right to appoint three additional directors to the Board
. . .
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant
The information required by this Item 2.03 is set forth under Item 1.01 above
and is hereby incorporated by reference in response to this Item.
Item 3.02 Unregistered Sales of Equity Securities
The information required by this Item 3.02 is set forth under Item 1.01 above
and is hereby incorporated by reference in response to this Item.
Item 3.03 Material Modification to Rights of Security Holders
The information required by this Item 3.03 is set forth under Item 1.01 above
and is hereby incorporated by reference in response to this Item.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
As previously described, pursuant to the terms of the A&R TSA, on the Closing
Date, certain corporate governance changes were made, including that John
Maldonado, an affiliate of Advent International Corporation, resigned from the
Company's Board and all committees of the Board of which he was a member,
effective as of the Closing Date. Andrew McKnight also notified the Board of his
intent to resign from the Company's Board and all committees of the Board of
which he was a member, effective as of the Closing Date. Messrs. Maldonado's and
McKnight's decisions to resign were not a result of any disagreement with the
Company or the Board on any matter relating to the Company's operations,
policies or practices.
Effective as of the Closing Date, pursuant to the terms of the A&R TSA and as
approved by the Board, Andrew Shannahan and Randy Raisman were appointed to the
Board to serve as independent directors with terms expiring at the Company's
2024 annual meeting of stockholders.
The newly appointed directors were elected pursuant to the rights granted to the
Preferred Equityholders, in addition to Daniel Dourney, who is an independent
director previously designated by the Preferred Equityholders. The Preferred
Equityholders anticipate that they will designate a third director at a later
date. There are no other arrangements or understandings between the directors
and any other persons pursuant to which they were elected as a director. Other
than with regard to the Transaction and rights granted to the Preferred
Equityholders, there are no transactions or proposed transactions between the
newly appointed directors and the Company that would be required to be disclosed
pursuant to Item 404(a) of Regulation S-K.
--------------------------------------------------------------------------------
The newly appointed directors will not receive any compensation for their Board
service. In connection with their appointments, the directors will enter into
standard indemnification agreements with the Company.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
The information required by this Item 5.03 set forth under Item 1.01 above
related to the A&R Series A COD and Series B COD is hereby incorporated by
reference in response to this Item.
Item 7.01 Regulation FD Disclosure
On June 15, 2023, the Company issued a press release announcing the closing of
the Transaction. A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated herein by reference.
The information in this Item 7.01, including Exhibit 99.1, is being furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act or the Exchange Act, regardless
of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits:
3.1 First Amended and Restated Certificate of Designation of Series A
Senior Preferred Stock of ATI Physical Therapy, Inc., filed on June 15, 2023.
3.2 Certificate of Designation of Series B Preferred Stock of ATI
Physical Therapy, Inc., filed on June 15, 2023.
10.1 Amended and Restated Transaction Support Agreement, dated April 17,
2023, by and among ATI Physical Therapy, Inc., ATI Holdings Acquisition, Inc.,
Wilco Intermediate Holdings, and other parties thereto (incorporated by
reference to Exhibit 10.1 to the Company's Form 8-K filed on April 21, 2023).
10.2 Amendment No. 2 to Credit Agreement, dated April 17, 2023, by and
among ATI Holdings Acquisition, Inc., Wilco Intermediate Holdings, Inc., HPS
Investment Partners, LLC, as Lender Representative and Barclays Bank PLC, as
Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company's
Form 8-K filed on April 21, 2023).
10.3 Consent to Amendment No. 2 to Credit Agreement, dated June 15,
2023, by and among ATI Holdings Acquisition, Inc., Wilco Intermediate Holdings,
Inc., HPS Investment Partners, LLC, as Lender Representative and Barclays Bank
PLC as Administrative Agent.
10.4 Second Lien Note Purchase Agreement, dated April 17, 2023, by and
among ATI Physical Therapy, Inc., Wilco Holdco, Inc., Wilco Intermediate
Holdings, Inc., ATI Holdings Acquisition, Inc., the Purchasers party thereto and
Wilmington Savings Fund Society, FSB (incorporated by reference to Exhibit 10.3
to the Company's Form 8-K filed on April 21, 2023).
10.5 First Amendment to the Investors' Rights Agreement, dated February
24, 2022, by and among the Company and the Preferred Equityholders party
thereto.
10.6 Registration Rights Agreement, dated June 15, 2023, by and among
the Company and certain Preferred Equityholders.
10.7 First Amendment to Note Purchase Agreement, dated June 15, 2023, by
and among ATI Physical Therapy, Inc., Wilco Holdco, Inc., Wilco Intermediate
Holdings, Inc., ATI Holdings Acquisition, Inc., the Subsidiary Guarantors party
thereto, the other Purchasers party thereto and Wilmington Savings Fund Society,
FSB.
99.1 Press Release of ATI Physical Therapy, Inc., dated June 15, 2023.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses